Furthermore, NEO1 overexpression inhibited the motility of CRC cells (HCT 116) and glioma cells (U251), and this inhibition was partially abolished after silencing NF2 (Fig. 5D, E and Supplementary Fig. S6C, D). The gene discussed is NEO1; the disease is central nervous system cancer.